Phase II Trial of Liposome Encapsulated SN38 (LE-SN38) in the Treatment of Small Cell Lung Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2016
At a glance
- Drugs LE SN38 (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Aug 2013 Status changed from suspended to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 11 Sep 2005 New trial record.